Lewes, DE -- (SBWIRE) -- 07/27/2018 -- Clinical Mass Spectrometry market will register a 6.2% CAGR in terms of revenue, reach US$ 920 million by 2023, from US$ 640 million in 2017.

Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics.

Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

The global production of the Clinical Mass Spectrometry is about 1931 units, North America is the largest production region, and the North America occupies about 63% of the market share. The second largest region is Europe, the region occupies about 25% market share, the Asia has little production, it only occupies about 10% market share in 2015. The largest company is Thermo Fisher, it occupies more than 26% of the market share, and the second largest company is AB Sciex (Danaher).

The largest consumption region is North America, it occupies about 46% market share in 2015, the second largest region is the Europe, it occupies about 32% market share, and the smallest consumption region is ROW, the consumption rate in China is about 6% in 2015.

In the last five years, the Clinical Mass Spectrometry has great consumption growth rate, it can be divided into two types LC-MS and GC-MS, the LC-MS occupies about 81% market share in 2015, in the application region, it mainly used in the Clinical Research, it occupies about 74% market share in 2015; In the future, the permeability will have high growth rate, the price have great relationship with the raw material and technology.

Over the next five years,study projects that Clinical Mass Spectrometry will register a 6.2% CAGR in terms of revenue, reach US$ 920 million by 2023, from US$ 640 million in 2017.

This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
Thermo Fisher
AB Sciex (Danaher)
Waters
Agilent
Bruker
Perkin Elmer
Shidmazu

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like
North America (United States, Canada and Mexico)
Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
Europe (Germany, UK, France, Italy and Russia etc.)
South America (Brazil, Chile, Peru and Argentina)
Middle East and Africa (Egypt, South Africa, Saudi Arabia)

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
LC-MS
GC-MS

Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
Clinical Diagnostics
Clinical Research

Spanning over 125 pages "Forecast of Global Clinical Mass Spectrometry Market 2023" report covers Clinical Mass Spectrometry Market Overview, Global Clinical Mass Spectrometry Sales, Revenue (Value) and Market Share by Players, Global Clinical Mass Spectrometry Sales, Revenue (Value) by Regions, Type and Application (2013-2018), North America Top 5 Players Clinical Mass Spectrometry Sales, Revenue and Price, Europe Top 5 Players Clinical Mass Spectrometry Sales, Revenue and Price, Asia-Pacific Top 5 Players Clinical Mass Spectrometry Sales, Revenue and Price, South America Top 5 Players Clinical Mass Spectrometry Sales, Revenue and Price, Middle East & Africa Top 5 Players Clinical Mass Spectrometry Sales, Revenue and Price, Global Clinical Mass Spectrometry Players Profiles/Analysis, Global Clinical Mass Spectrometry Market Forecast (2018-2023), Clinical Mass Spectrometry Manufacturing Cost Analysis, Industrial Chain, Sourcing Strategy and Downstream Buyers, Marketing Strategy Analysis, Distributors/Traders, Market Effect Factors Analysis, Research Findings and Conclusion, Appendix.

Please visit this link for more details: https://www.marketresearchreports.com/mrrpb2/forecast-global-clinical-mass-spectrometry-market-2023

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

For related reports please visit: https://www.marketresearchreports.com/search/site/Clinical%2520Mass%2520Spectrometry

Read our Interactive Market Research Blog

About MarketResearchReprots.com
MarketResearchReprots.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Contact us for your market research requirements:https://www.marketresearchreports.com/contact